D-C Liang
Overview
Explore the profile of D-C Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang D, Yang C, Liu H, Jaing T, Chen S, Hung I, et al.
Pharmacogenomics J
. 2015 Oct;
16(6):536-539.
PMID: 26503813
A recent study identified a variant of the NUDT15 gene (rs116855232 C>T) associated with intolerance to thiopurine in Korean patients with Crohn's disease. This study prompted us to substantiate the...
2.
Liang D, Yang C, Lin D, Hung I, Lin K, Chen J, et al.
Leukemia
. 2009 Dec;
24(2):397-405.
PMID: 20016538
The long-term outcome of 1390 children with acute lymphoblastic leukemia (ALL), treated in two successive clinical trials (Taiwan Pediatric Oncology Group (TPOG)-ALL-97 and TPOG-ALL-2002) between 1997 and 2007, is reported....
3.
Kuo M, Liang D, Huang C, Shih Y, Wu J, Lin T, et al.
Leukemia
. 2009 Mar;
23(8):1426-31.
PMID: 19282830
Runt-related transcription factor 1 (RUNX1) is essential for normal hematopoiesis. RUNX1 mutations have rarely been reported in chronic myelomonocytic leukemia (CMML). We examined RUNX1 mutations in 81 patients with CMML...
4.
Shih L, Liang D, Huang C, Chang Y, Lai C, Lin T, et al.
Leukemia
. 2007 Oct;
22(2):303-7.
PMID: 17960171
c-KIT mutations have been described in core-binding factor (CBF) acute myeloid leukemia (AML) at diagnosis. The role of c-KIT mutations in the relapse of CBF-AML is not clear. The role...
5.
Wang L, Liang D, Liu H, Chang F, Wang C, Chan Y, et al.
Transfus Med
. 2006 Jun;
16(3):200-3.
PMID: 16764599
The development of erythrocyte alloantibodies complicates transfusion therapy in patients with thalassemia. However, no data are available on the frequency of erythrocyte alloimmunization in patients with transfusion-dependent thalassemia in Taiwan....
6.
Shih L, Liang D, Huang C, Wu J, Lin T, Wang P, et al.
Leukemia
. 2006 Feb;
20(4):604-9.
PMID: 16453003
The roles of CEBPalpha mutations and its cooperating mutations in the relapse of acute myeloid leukemia (AML) are not clear. CEBPalpha mutations were analyzed on 149 patients with de novo...
7.
Shih L, Liang D, Fu J, Wu J, Wang P, Lin T, et al.
Leukemia
. 2005 Dec;
20(2):218-23.
PMID: 16341046
The fusion transcripts of MLL rearrangement [MLL(+)] in acute myeloid leukemia (AML) and their clinicohematologic correlation have not be well characterized in the previous studies. We used Southern blot analysis...
8.
Liang D, Shih L, Huang C, Hung I, Yang C, Liu H, et al.
Leukemia
. 2004 Dec;
19(3):410-4.
PMID: 15618961
CEBPalpha: mutations have been described in adult acute myeloid leukemia (AML) and conferred a favorable prognosis. However, CEBPalpha mutation has not been reported in children. We investigated 117 children with...
9.
Liang D, Shih L, Hung I, Yang C, Chen S, Jaing T, et al.
Leukemia
. 2003 May;
17(5):883-6.
PMID: 12750701
Mutations of receptor tyrosine kinases are implicated in the constitutive activation and development of human hematologic malignancies. An internal tandem duplication (ITD) of the juxtamembrane domain-coding sequence of the FLT3...